Back to Search
Start Over
Letter: should we abandon FIB‐4 to characterise noninvasively patients with NAFLD? Authors' reply.
- Source :
- Alimentary Pharmacology & Therapeutics; Apr2023, Vol. 57 Issue 8, p922-923, 2p
- Publication Year :
- 2023
-
Abstract
- LINKED CONTENT: This article is linked to Younossi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17346 and https://doi.org/10.1111/apt.17422 [ABSTRACT FROM AUTHOR]
- Subjects :
- NON-alcoholic fatty liver disease
AUTHORS
PATIENTS
Subjects
Details
- Language :
- English
- ISSN :
- 02692813
- Volume :
- 57
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Alimentary Pharmacology & Therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 162643668
- Full Text :
- https://doi.org/10.1111/apt.17448